Thus, researchers have identified small molecule inhibitors with anticancer activity to treat KRAS-driven cancers (Kumar and Priya Doss, 2021a; Kumar and Priya Doss, 2021b; Udhaya Kumar et al., 2022). The gene discussed is KRAS; the disease is cancer.